Duloxetine hydrochloride and Cervix carcinoma - a phase IV clinical study of FDA data

Summary:

Cervix carcinoma is reported only by a few people who take Duloxetine Hydrochloride.

The phase IV clinical study analyzes which people take Duloxetine hydrochloride and have Cervix carcinoma. It is created by eHealthMe based on reports of 14,123 people who have side effects while taking Duloxetine hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

14,123 people reported to have side effects when taking Duloxetine hydrochloride.
Among them, 2 people (0.01%) have Cervix carcinoma.

What is Duloxetine hydrochloride?

Duloxetine hydrochloride has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 15,002 Duloxetine hydrochloride users for its effectiveness, alternative drugs and more.

What is Cervix carcinoma?

Cervix carcinoma (cancer of cervix) is found to be associated with 752 drugs and 409 conditions by eHealthMe.

Number of Duloxetine hydrochloride and Cervix carcinoma reports submitted per year:

Could Duloxetine hydrochloride cause Cervix carcinoma?

Age of people who have Cervix carcinoma when taking Duloxetine hydrochloride *:

Common drugs people take besides Duloxetine hydrochloride *:

Zoloft: 1 person, 50.00%
Lanoxin: 1 person, 50.00%
Glucophage: 1 person, 50.00%
Glucovance: 1 person, 50.00%
Glyburide: 1 person, 50.00%
Imdur: 1 person, 50.00%
Isosorbide Mononitrate: 1 person, 50.00%
Klor-Con: 1 person, 50.00%
Lantus: 1 person, 50.00%
Fluoxetine: 1 person, 50.00%

Common side effects people have besides Cervix carcinoma *:

Weight Loss: 1 person, 50.00%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 50.00%
Dyspnea Paroxysmal Nocturnal: 1 person, 50.00%
Fainting (loss of consciousness and postural tone): 1 person, 50.00%
Gastritis (inflammation of stomach): 1 person, 50.00%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 50.00%
Headache (pain in head): 1 person, 50.00%
Hepatic Steatosis (fatty liver disease): 1 person, 50.00%
High Blood Pressure: 1 person, 50.00%
Histrionic Personality Disorder (long-standing pattern of attention seeking behaviour and extreme emotionality): 1 person, 50.00%

Common conditions people have *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Duloxetine hydrochloride and have Cervix carcinoma?

Check whether Cervix carcinoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Duloxetine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Cervix carcinoma treatments and more:

Cervix carcinoma (7,218 reports)

COVID vaccines that are related to Cervix carcinoma:

Common drugs associated with Cervix carcinoma:

All the drugs that are associated with Cervix carcinoma:

Cervix carcinoma (752 drugs)

Common conditions associated with Cervix carcinoma:

Gastroesophageal reflux disease: 684 reports
Multiple sclerosis: 381 reports
Rheumatoid arthritis: 300 reports
Gastric ulcer: 299 reports
Crohn's disease: 124 reports
Birth control: 121 reports

All the conditions that are associated with Cervix carcinoma:

Cervix carcinoma (409 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Duloxetine hydrochloride) and Duloxetine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.